Atheroprotective Aspects of Heat Shock Proteins
Atherosclerosis is a major global health problem. Being a harbinger of a large number of cardiovascular diseases, it ultimately leads to morbidity and mortality. At the same time, effective measures for the prevention and treatment of atherosclerosis have not been developed, to date. All available therapeutic options have a number of limitations. To understand the mechanisms behind the triggering and development of atherosclerosis, a deeper understanding of molecular interactions is needed. Heat shock proteins are important for the normal functioning of cells, actively helping cells adapt to gradual changes in the environment and survive in deadly conditions. Moreover, multiple HSP families play various roles in the progression of cardiovascular disorders. Some heat shock proteins have been shown to have antiatherosclerotic effects, while the role of others remains unclear. In this review, we considered certain aspects of the antiatherosclerotic activity of a number of heat shock proteins.
Top-30
Journals
|
1
|
|
|
Heliyon
1 publication, 8.33%
|
|
|
Journal of Clinical Medicine
1 publication, 8.33%
|
|
|
Journal of Inflammation Research
1 publication, 8.33%
|
|
|
Vascular Pharmacology
1 publication, 8.33%
|
|
|
Chemical & Biomedical Imaging
1 publication, 8.33%
|
|
|
Frontiers in Cardiovascular Medicine
1 publication, 8.33%
|
|
|
Molecular and Cellular Biochemistry
1 publication, 8.33%
|
|
|
Frontiers in Bioscience-Landmark
1 publication, 8.33%
|
|
|
International Journal of Nanomedicine
1 publication, 8.33%
|
|
|
Cardiology Plus
1 publication, 8.33%
|
|
|
Frontiers in Immunology
1 publication, 8.33%
|
|
|
International Journal of Molecular Sciences
1 publication, 8.33%
|
|
|
1
|
Publishers
|
1
2
|
|
|
Elsevier
2 publications, 16.67%
|
|
|
MDPI
2 publications, 16.67%
|
|
|
Taylor & Francis
2 publications, 16.67%
|
|
|
Frontiers Media S.A.
2 publications, 16.67%
|
|
|
American Chemical Society (ACS)
1 publication, 8.33%
|
|
|
Springer Nature
1 publication, 8.33%
|
|
|
IMR Press
1 publication, 8.33%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 8.33%
|
|
|
1
2
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.